SEC Form 4 · accession 0001393905-18-000001
Biohaven Pharmaceutical Holding Co Ltd. · BHVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
PORTAGE BIOTECH INC.
10% Owner
Period of report
Jan 3, 2018
Accepted (ET)
Jan 4, 2018 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001689813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 3, 2018 | S | 35,650 | $28.6135 | D | 6,305,850 | D |
Table II — derivative securities
No Table II lines on this filing.